UMIN-ICDS History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000051259 |
|---|---|
| Receipt number | R000058453 |
| Scientific Title | A multicenter prospective observational study to confirm the effectiveness and safety of trastuzumab deruxtecan for unresectable and/or metastatic breast cancer patients with HER2-low expression |
| Date of disclosure of the study information | 2023/06/16 |
| Last modified on | 2023/10/02 18:23:58 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2023/06/05 11:19:45 | ||
| 2 | Update | 2023/06/08 15:34:08 | Date of disclosure of the study information |
|
| 3 | Update | 2023/06/14 14:34:27 | Anticipated trial start date |
|
| 4 | Update | 2023/06/16 08:30:04 | Recruitment status |
|
| 5 | Update | 2023/10/02 18:23:58 | Name of person sending information Name of person sending information |
